Collegium Pharmaceutical Inc (COLL)

Total asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	631,449	599,245	576,653	566,923	566,767	546,642	536,946	524,949	463,933	361,675	313,505	272,898	276,868	325,777	326,110	321,226	310,016	307,948	301,714	298,696
Total assets	US$ in thousands	1,663,590	1,635,150	1,053,390	1,114,250	1,143,310	1,177,580	1,213,910	1,214,300	1,174,130	1,200,940	1,245,570	1,246,140	692,077	741,803	713,735	646,065	643,841	643,843	646,870	634,793
Total asset turnover		0.38	0.37	0.55	0.51	0.50	0.46	0.44	0.43	0.40	0.30	0.25	0.22	0.40	0.44	0.46	0.50	0.48	0.48	0.47	0.47

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $631,449K ÷ $1,663,590K
= 0.38

Collegium Pharmaceutical Inc's total asset turnover has fluctuated over the past few years. The ratio was relatively stable around 0.47 to 0.48 from March 2020 to December 2021, indicating that the company was generating approximately $0.47 to $0.48 in sales for every dollar of assets it owned during this period.

However, from March 2022 to June 2024, there was a noticeable decline in total asset turnover, with the ratio dropping to as low as 0.22 before gradually increasing back to 0.38 by December 2024. This downward trend suggests that Collegium Pharmaceutical Inc may have experienced challenges in efficiently utilizing its assets to generate revenue during this period.

It's important for the company to closely monitor and improve its total asset turnover to ensure optimal asset utilization and profitability in the future.